Skip to content
SafetyScorer

Is Pregabalin safe?

Pregabalin

Pregabalin (Lyrica, Alzain, Axalid) treats nerve pain, fibromyalgia and seizures, and in the UK anxiety. Dizziness and drowsiness affect many users, it is a controlled drug in the US and UK because of misuse, and combined with opioids, alcohol or other sedatives it can cause fatal breathing problems.

High confidence#52 of 65 medicationsUpdated
Spot a mistake?
Brands
Lyrica, Lyrica CR; Alzain, Axalid, Lecaent (UK)
Legal status
Controlled substanceA medicine or drug that the law restricts because it can be misused or cause dependence. Countries group them into schedules or classes.More in the glossary in the US; Class C, Schedule 3 in the UK since April 2019
Boxed warning
None
Usual adult dose
Start 150 mg a day; maximum 300 to 600 mg a day depending on the condition (US label)
Dizziness in trials
30% vs 8% on placebo
Euphoria in trials
4% vs 1% on placebo
Deaths mentioning pregabalin, England and Wales
617 registered in 2024, up from 38 in 2014 (ONS)

How the score breaks down

The overall score is the weighted average of these factors. Scoring rules

  • Serious side effects30% of score

    62 out of 100, Fair

    In US label trials, 30% had dizziness and 23% drowsiness against 8% on placebo; 9% gained 7% or more of body weight and 6% had swollen legs. Rare serious effects include angioedema and breathing depression. A Nordic study suggests a slightly higher birth defect risk.

  • Overdose margin20% of score

    55 out of 100, Fair

    The label reports deaths after overdoses of pregabalin alone and with other sedatives, plus seizures and heart block. Deaths in England and Wales mentioning pregabalin rose from 38 in 2014 to 617 in 2024 (ONS); only 16 involved no other drug.

  • Interactions15% of score

    50 out of 100, Weak

    Few drugs change its levels, as it leaves the body unchanged in urine. The risk is additive sedation. Opioids, benzodiazepines, alcohol and gabapentin can cause fatal breathing problems, and the MHRA says doses above 300 mg a day with opioids are linked to higher opioid death risk.

  • Dependence and misuse15% of score

    45 out of 100, Weak

    Controlled substanceA medicine or drug that the law restricts because it can be misused or cause dependence. Countries group them into schedules or classes.More in the glossary in the US. Recreational sedative users rated a single 450 mg dose much like 30 mg of diazepam, and 4% of trial patients reported euphoria. Withdrawal includes insomnia, nausea, anxiety and seizures, so the label says to taper over at least a week.

  • Regulatory warnings10% of score

    50 out of 100, Weak

    No Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary, but controlled in the US and, since April 2019, as a Class C drug in the UK. FDA breathing warning in 2019; MHRA warnings on breathing (2021), pregnancy (2022) and stronger addiction labelling (2026).

  • Track record10% of score

    85 out of 100, Excellent

    Approved in the US on 30 December 2004 and widely prescribed worldwide, so over 20 years of data; the misuse and death trends emerged mainly in the last decade.

Is pregabalin safe?

Pregabalin is reasonably safe for most people who take it as prescribed, but it has a narrower safety margin than its reputation suggests. About 1 in 3 users feels dizzy and 1 in 4 drowsy in trials. It is controlled in both the US and the UK because people misuse it. And with opioids, alcohol or other sedatives it can slow breathing enough to kill. We score it 57, below gabapentin and above alprazolam.

In the US it is approved for diabetic nerve pain, nerve pain after shingles, nerve pain after spinal cord injury, fibromyalgia and as add-on treatment for partial seizures. In the UK it is also licensed for generalised anxiety disorder.

Breathing problems: who is at risk

The US label warns of serious, life-threatening or fatal breathing depression when pregabalin is taken with other sedatives, especially opioids, or by people whose breathing is already weak. It adds that there is more limited evidence of serious breathing depression without either. The FDA required this warning in December 2019 for both gabapentinoids.

The UK went further in February 2021. The MHRA said pregabalin had been linked to breathing depression in some people who were not taking opioids, and that studies link doses above 300 mg a day taken alongside opioids with a higher risk of opioid-related death. From 2014 to 2020 it received 122 UK reports of breathing problems; 80 also involved another sedative. Most cases were in older people. Its higher-risk list:

  • lung or neurological disease, or reduced kidney function
  • other brain-slowing medicines, including opioids, benzodiazepines and gabapentin
  • age over 65

Misuse and rising deaths

Pregabalin does not act on opioid or benzodiazepine receptors, but the US label reports that recreational users rated a 450 mg dose much like 30 mg of diazepam for "high" and "liking". In clinical trials, 4% of patients reported euphoria against 1% on placebo.

That is the background to rising deaths. In England and Wales, pregabalin was mentioned on 38 drug poisoning death certificates registered in 2014 and 617 in 2024, according to the ONS. Only 16 of the 2024 deaths involved no other drug, and 134 involved alcohol. The UK made pregabalin and gabapentin Class C, Schedule 3 Controlled substanceA medicine or drug that the law restricts because it can be misused or cause dependence. Countries group them into schedules or classes.More in the glossary on 1 April 2019, so prescriptions are valid for 28 days. In January 2026 the MHRA announced stronger warnings on addiction, dependence and withdrawal on UK leaflets and packs.

Stopping suddenly can cause insomnia, nausea, headache, diarrhoea, anxiety and, rarely, seizures. The label says to taper over at least one week; the MHRA notes that coming off a high dose can take weeks or months.

Doses on the label

Use (US label)StartMaximum
Diabetic nerve pain50 mg three times a day300 mg a day
Nerve pain after shingles150 mg a day in 2 or 3 doses600 mg a day
Fibromyalgia75 mg twice a day450 mg a day
Spinal cord injury pain75 mg twice a day600 mg a day
Partial seizures, adults150 mg a day600 mg a day

For diabetic nerve pain, 600 mg a day was studied but gave no clear extra benefit and was less well tolerated. Doses are lower for people with reduced kidney function, because pregabalin leaves the body through the kidneys.

Other side effects worth knowing

Dizziness (30% against 8% on placebo) and drowsiness (23% against 8%) usually start early and rise with dose; among those affected in short trials, dizziness lasted to the final dose in 30% and drowsiness in 42%. Swollen legs affected 6%, and weight gain is common. Angioedema, swelling of the face, mouth and throat, can threaten breathing and means stopping at once and getting emergency help.

In pregnancy, a Nordic study of more than 2,700 first-trimester exposures found major birth defects in 5.9% of babies against 4.1% in unexposed pregnancies, and modestly higher risk than with lamotrigine or duloxetine. The MHRA advises avoiding pregabalin in pregnancy unless clearly necessary, and using effective contraception.

Who should be careful

Talk to your doctor or pharmacist before taking pregabalin if you take an opioid such as oxycodone, a benzodiazepine or sleeping pills, drink alcohol, have lung, heart or kidney disease, are over 65, have ever misused drugs or alcohol, or could become pregnant. Do not drive until you know how it affects you, keep it out of reach of others, and do not stop it suddenly without a plan from your prescriber.

How we scored it

Track record (85) is the strongest factor after two decades of use. Serious side effects (62) and Overdose marginHow far a normal dose is from a harmful one. A wide margin means an accidental extra dose is unlikely to cause serious harm.More in the glossary (55) are middling because harm at normal doses is uncommon, but overdose deaths are rising. Dependence (45), interactions (50) and regulatory warnings (50) are lower than for gabapentin because pregabalin is controlled in the US, has measurable euphoric effects, and has drawn more UK safety warnings.

Questions people ask

Is pregabalin addictive?

It can be. In the US it is a Controlled substanceA medicine or drug that the law restricts because it can be misused or cause dependence. Countries group them into schedules or classes.More in the glossary controlled substance and in the UK a Class C drug. In a study of recreational sedative users, a 450 mg dose was liked about as much as 30 mg of diazepam. Drug dependenceThe body's adaptation to a drug taken regularly, so that stopping it suddenly causes withdrawal symptoms. It is not the same as addiction.More in the glossary can develop with regular use even without misuse, so plan any change with your prescriber.

Can I drink alcohol on pregabalin?

The MHRA advises avoiding alcohol during pregabalin treatment. Both slow the brain, and together they increase drowsiness, dizziness, falls and the risk of breathing problems.

Is pregabalin stronger than gabapentin?

Milligram for milligram, yes. Pregabalin is at least 90% absorbed at any dose, while gabapentin absorption falls as the dose rises, so pregabalin doses are much smaller (150 to 600 mg a day against 900 to 3,600 mg for gabapentin). It also has more evidence of misuse, which is why the US controls pregabalin but not gabapentin. Which one suits a person is a decision for the prescriber.

Does pregabalin cause weight gain?

Often. In US trials of up to 14 weeks, 9% of people on pregabalin gained 7% or more of their body weight, against 2% on placebo, and diabetic patients treated for two years gained 5.2 kg on average. Swollen ankles are also common.

Can I take pregabalin while pregnant?

The MHRA advises avoiding it in pregnancy unless clearly necessary, because a Nordic study of more than 2,700 exposed pregnancies found a slightly higher rate of major birth defects. Do not stop it suddenly if you become pregnant; speak to your doctor promptly.

Sources

  1. 1.LYRICA (pregabalin) capsules and oral solution label (opens in a new tab) · DailyMed / Viatris, 2025
  2. 2.Pregabalin (Lyrica): reports of severe respiratory depression (opens in a new tab) · MHRA Drug Safety Update, 2021
  3. 3.Pregabalin (Lyrica): findings of safety study on risks during pregnancy (opens in a new tab) · MHRA Drug Safety Update, 2022
  4. 4.Deaths related to drug poisoning by selected substances, England and Wales, 1993 to 2024 (opens in a new tab) · Office for National Statistics, 2025
  5. 5.Improving information supplied with gabapentinoids, benzodiazepines and Z-drugs (opens in a new tab) · MHRA Drug Safety Update, 2026
  6. 6.Pregabalin (opens in a new tab) · NHS, 2026
Spot a mistake?